Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Cirrhosis

  Free Subscription

Articles published in Intern Med

Retrieve available abstracts of 29 articles:
HTML format

Single Articles

    September 2021
  1. USAMI J
    Primary Biliary Cholangitis-associated Palmar Keratosis.
    Intern Med. 2021;60:2877.

    June 2021
  2. KOYAMA M, Yamazaki T, Joshita S, Ito A, et al
    An Autopsy Case of Primary Biliary Cholangitis with Histological Submassive Hepatic Necrosis Caused by Acute Hepatitis E Virus Infection.
    Intern Med. 2021;60:1863-1870.
    PubMed     Abstract available

  3. HONMA Y, Shibata M, Gohda T, Matsumiya H, et al
    Rapid Progression of Liver Fibrosis Induced by Acute Liver Injury Due to Immune-related Adverse Events of Atezolizumab.
    Intern Med. 2021;60:1847-1853.
    PubMed     Abstract available

    May 2021
  4. HAMAHATA A, Mitsusada S, Iwata T, Nakajima K, et al
    A Case of Liver Cirrhosis Complicated by Spontaneous Bacterial Peritonitis Caused by the Burkholderia cepacia complex.
    Intern Med. 2021 May 14. doi: 10.2169/internalmedicine.7170.
    PubMed     Abstract available

  5. KOGAMI T, Uojima H, Ebato T, Bando Y, et al
    Cartilage-hair Hypoplasia Complicated with Liver Cirrhosis Due to Chronic Intrahepatic Cholestasis: A Case Report.
    Intern Med. 2021 May 7. doi: 10.2169/internalmedicine.7483.
    PubMed     Abstract available

    March 2021
  6. SHIGEFUKU R, Iwasa M, Yoshikawa K, Takei Y, et al
    A Rare Presentation of Intraperitoneal Ectopic Varices Rupture.
    Intern Med. 2021;60:959-960.

  7. KATO S, Sakamori R, Yamada R, Murai K, et al
    The First Case of Coil Embolization for Left Gastric Vein Aneurysm with Liver Cirrhosis: A Case Report and Review of the Literature.
    Intern Med. 2021 Mar 8. doi: 10.2169/internalmedicine.6565.
    PubMed     Abstract available

    February 2021
  8. TOTSUKA M, Honda M, Kanda T, Ishii T, et al
    Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir.
    Intern Med. 2021 Feb 1. doi: 10.2169/internalmedicine.6728.
    PubMed     Abstract available

    January 2021
  9. SAKAMORI R, Yamada R, Shinkai K, Doi A, et al
    Improvement of Skeletal Muscle Mass after Ledipasvir and Sofosbuvir Treatment for Hepatitis C Virus in Decompensated Liver Cirrhosis.
    Intern Med. 2021;60:745-750.
    PubMed     Abstract available

  10. FUJIWARA Y, Suzuki K, Yusa K, Eizuka M, et al
    Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
    Intern Med. 2021;60:1027-1033.
    PubMed     Abstract available

  11. YOKOKAWA T, Yoshihisa A, Misaka T, Sato T, et al
    Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy.
    Intern Med. 2021;60:201-208.
    PubMed     Abstract available

  12. SHIGEFUKU R, Iwasa M, Eguchi A, Tempaku M, et al
    Serum Copeptin and Zinc-alpha2-glycoprotein Levels Are Novel Biomarkers of Tolvaptan Treatment in Decompensated Cirrhotic Patients with Ascites.
    Intern Med. 2021;60:3359-3368.
    PubMed     Abstract available

  13. ABE K, Fujita M, Hayashi M, Takahashi A, et al
    The Efficacy of Levocarnitine Treatment in Relieving Fatigue in Patients with Cirrhosis but without Overt Hepatic Encephalopathy.
    Intern Med. 2021;60:3533-3542.
    PubMed     Abstract available

    December 2020
  14. TATSUMI R, Suii H, Yamaguchi M, Arakawa T, et al
    Efficacy of Switching from Kanamycin Sulfate to Rifaximin in Patients with Hepatic Cirrhosis.
    Intern Med. 2020 Dec 22. doi: 10.2169/internalmedicine.6039.
    PubMed     Abstract available

  15. ISHIKAWA T, Sasaki R, Nishimura T, Matsuda T, et al
    Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh Classification.
    Intern Med. 2020 Dec 7. doi: 10.2169/internalmedicine.6267.
    PubMed     Abstract available

  16. SHIMADA M, Hirashima N, Iwase H, Saito M, et al
    Evaluation of Muscle Cramp Associated with Liver Cirrhosis with a Focus on the Liver Function and Nutritional Status.
    Intern Med. 2020 Dec 7. doi: 10.2169/internalmedicine.6231.
    PubMed     Abstract available

  17. KAWANAKA M, Nishino K, Morimoto Y, Ishii K, et al
    Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years: A Case Report.
    Intern Med. 2020 Dec 7. doi: 10.2169/internalmedicine.6118.
    PubMed     Abstract available

    October 2020
  18. NISHINO K, Kawanaka M, Suehiro M, Yoshioka N, et al
    Gastric Hyperplastic Polyps after Argon Plasma Coagulation for Gastric Antral Vascular Ectasia in Patients with Liver Cirrhosis - A Case Suggesting the "Gastrin Link Theory".
    Intern Med. 2020 Oct 28. doi: 10.2169/internalmedicine.5837.
    PubMed     Abstract available

    July 2020
  19. TANIGUCHI Y, Takahashi N, Miura M, Hirase C, et al
    The Impact of Hemodialysis and Liver Cirrhosis on the Plasma Concentrations of Tyrosine Kinase Inhibitors in a Patient with Chronic Myeloid Leukemia.
    Intern Med. 2020 Jul 7. doi: 10.2169/internalmedicine.4871.
    PubMed     Abstract available

  20. SEIKE T, Komura T, Shimizu Y, Omura H, et al
    The Serum Mac-2-binding Protein Glycosylation Isomer Dynamics in Acute Liver Injury.
    Intern Med. 2020;59:1581-1588.
    PubMed     Abstract available

    May 2020
  21. KIMURA N, Tsuchiya A, Oda C, Kimura A, et al
    Portal Vein Thrombosis Associated with Trousseau Syndrome due to Urinary Bladder Squamous Cell Carcinoma in a Liver Cirrhosis Patient.
    Intern Med. 2020 May 23. doi: 10.2169/internalmedicine.4112.
    PubMed     Abstract available

    April 2020
  22. SAKAMAKI A, Yokoyama K, Yamazaki F, Kamimura H, et al
    Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis: A Case Report.
    Intern Med. 2020 Apr 23. doi: 10.2169/internalmedicine.4593.
    PubMed     Abstract available

  23. MIZUNO Y, Ishikawa T, Ishida J, Kobayashi A, et al
    The Molar Ratio of Total Branched-chain Amino Acids to Tyrosine Predicts a Digit Symbol Test Abnormality in Cirrhotic Patients.
    Intern Med. 2020 Apr 16. doi: 10.2169/internalmedicine.4298.
    PubMed     Abstract available

  24. HARAGUCHI M, Hirai S, Nakamura Y, Otsuka T, et al
    Intractable Hepatic Encephalopathy with a Large Portosystemic Shunt Successfully Treated Using Shunt-preserving Disconnection of the Portal and Systemic Circulation.
    Intern Med. 2020;59:1047-1051.
    PubMed     Abstract available

  25. SAWADA K, Takai A, Yamada T, Araki O, et al
    Hepatitis-associated Aplastic Anemia with Rapid Progression of Liver Fibrosis Due to Repeated Hepatitis.
    Intern Med. 2020;59:1035-1040.
    PubMed     Abstract available

    February 2020
  26. AKUTA N, Kawamura Y, Fujiyama S, Sezaki H, et al
    Predictors of Insulin Secretion in Japanese Patients with Histopathologically-confirmed Non-alcoholic Fatty Liver Disease.
    Intern Med. 2020;59:329-338.
    PubMed     Abstract available

    January 2020
  27. SEKO Y, Moriguchi M, Takahashi A, Okishio S, et al
    The Association between the Platelet Count and Liver Volume in Compensated Cirrhosis Patients after the Eradication of Hepatitis C virus by Direct-acting Antivirals.
    Intern Med. 2020;59:1811-1817.
    PubMed     Abstract available

  28. YOKOYAMA K, Tsuchiya N, Yamauchi R, Miyayama T, et al
    Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension.
    Intern Med. 2020;59:2089-2094.
    PubMed     Abstract available

  29. ISHIKAWA T, Endo S, Imai M, Azumi M, et al
    Changes in the Body Composition and Nutritional Status after Long-term Rifaximin Therapy for Hyperammonemia in Japanese Patients with Hepatic Encephalopathy.
    Intern Med. 2020;59:2465-2469.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.